Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the realm of Anti-PD-1 antibodies / PD-1 inhibitors concerning Hodgkin lymphoma, the checkpoint inhibitors nivolumab and pembrolizumab serve as primary treatment options for cases of relapsed or refractory classic Hodgkin lymphoma. For patients who either decline autologous stem-cell transplantation or are not suitable candidates for high-dose chemotherapy followed by autologous ste…